West Michigan Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AIM
FWIA
DLA
ETC
West Michigan Advisors's BMY Position: Q2 2026 in Review
West Michigan Advisors held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 66,662 shares worth $4.04M. The position accounts for 0.89% of the portfolio, ranked #25.
West Michigan Advisors first reported a position in BMY in Q4 2021 and has held it in 8 quarters since. 830 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- West Michigan Advisors held 66,662 shares of Bristol-Myers Squibb worth $4.04M as of Q2 2026.
- West Michigan Advisors left its Bristol-Myers Squibb share count unchanged in Q2 2026.
- Bristol-Myers Squibb made up 0.89% of West Michigan Advisors's portfolio in Q2 2026, its #25 holding.
- West Michigan Advisors first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 8 quarters since.
- 830 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on West Michigan Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.